Antibodies tend to be the main course of therapeutics, owing in large part to their power to connect with unique ligand conformations so as to elicit distinct biological responses. Nonetheless, discovery of new molecules binding unique epitopes is time-consuming and demanding, specifically for predicaments demanding a certain antibody-ligand orient